HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Tang Selected Research

JTT 501

7/2001Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Tang Research Topics

Disease

45Neoplasms (Cancer)
03/2022 - 01/2000
18Infections
03/2022 - 03/2000
12Breast Neoplasms (Breast Cancer)
11/2021 - 06/2000
11Neoplasm Metastasis (Metastasis)
08/2018 - 01/2003
8Inflammation (Inflammations)
08/2017 - 02/2001
7Necrosis
08/2019 - 01/2010
7Wounds and Injuries (Trauma)
08/2019 - 12/2000
6Insulin Resistance
10/2019 - 07/2001
5Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 07/2013
5Type 2 Diabetes Mellitus (MODY)
10/2019 - 01/2008
4Proteinuria
01/2021 - 12/2006
4Hypoxia (Hypoxemia)
11/2020 - 12/2001
4Fibrosis (Cirrhosis)
08/2020 - 07/2000
4Cicatrix (Scar)
04/2019 - 03/2007
4Myocardial Infarction
05/2015 - 08/2001
4Infarction (Infarctions)
08/2005 - 07/2000
3Thyroid Neoplasms (Thyroid Cancer)
10/2022 - 10/2015
3Stomach Neoplasms (Stomach Cancer)
03/2022 - 05/2014
3Hypertension (High Blood Pressure)
08/2021 - 01/2017
3Brain Injuries (Brain Injury)
08/2021 - 01/2013
3Body Weight (Weight, Body)
05/2021 - 09/2008
3Hypersensitivity (Allergy)
01/2021 - 07/2000
3Hepatitis C
10/2020 - 03/2001
3Acute Kidney Injury (Acute Renal Failure)
09/2020 - 07/2017
3Atrophy
08/2020 - 01/2013
3Nasopharyngeal Carcinoma
09/2019 - 07/2007
3Sepsis (Septicemia)
04/2019 - 02/2001
3Asthma (Bronchial Asthma)
04/2018 - 03/2001
3Burns
09/2017 - 02/2001
3Prostatic Neoplasms (Prostate Cancer)
01/2017 - 01/2004
3Lung Neoplasms (Lung Cancer)
01/2017 - 11/2010
3Virus Diseases (Viral Diseases)
12/2016 - 12/2000
3Carcinogenesis
05/2016 - 02/2006
3Ischemic Stroke
01/2016 - 12/2001
3Hypothermia
03/2015 - 09/2012
3Mitochondrial Diseases (Mitochondrial Disease)
11/2014 - 07/2000
3Leukemia
01/2014 - 04/2001
3Ischemia
08/2005 - 01/2000
2Carcinoma (Carcinomatosis)
03/2022 - 10/2012
2Lung Injury
03/2022 - 09/2014
2Glioma (Gliomas)
01/2022 - 05/2003
2Cardiovascular Diseases (Cardiovascular Disease)
06/2020 - 10/2019
2Pain (Aches)
01/2020 - 06/2011
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2019 - 02/2013
2Adenocarcinoma of Lung
10/2019 - 08/2014
2Chronic Renal Insufficiency
10/2019 - 10/2017
2Trismus (Lockjaw)
09/2019 - 01/2011

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
06/2019 - 11/2001
8Pharmaceutical PreparationsIBA
03/2022 - 03/2004
8MicroRNAs (MicroRNA)IBA
09/2021 - 06/2013
8AntigensIBA
10/2018 - 01/2001
8CytokinesIBA
12/2016 - 06/2000
6EnzymesIBA
03/2022 - 02/2000
6Biological ProductsIBA
10/2019 - 10/2001
6Biomarkers (Surrogate Marker)IBA
06/2019 - 05/2008
6Messenger RNA (mRNA)IBA
11/2018 - 11/2009
6EpitopesIBA
01/2011 - 01/2001
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 01/2013
5CreatinineIBA
01/2021 - 12/2006
5DNA (Deoxyribonucleic Acid)IBA
04/2016 - 01/2000
5VaccinesIBA
02/2013 - 07/2000
5Transforming Growth Factor beta (TGF-beta)IBA
01/2010 - 08/2001
4Interleukin-6 (Interleukin 6)IBA
03/2022 - 11/2011
4NitrogenIBA
09/2020 - 12/2006
4Glucose (Dextrose)FDA LinkGeneric
10/2019 - 09/2008
4Therapeutic UsesIBA
09/2019 - 06/2000
4RNA (Ribonucleic Acid)IBA
04/2019 - 03/2001
4Anti-Bacterial Agents (Antibiotics)IBA
12/2014 - 05/2000
4Peptides (Polypeptides)IBA
09/2001 - 06/2000
3sodium-iodide symporter (sodium iodide symporter)IBA
10/2022 - 10/2015
3Cadherins (E-Cadherin)IBA
05/2021 - 03/2006
3Transcription Factors (Transcription Factor)IBA
11/2020 - 04/2015
3Urea (Carbamide)FDA LinkGeneric
09/2020 - 12/2006
3Long Noncoding RNAIBA
04/2019 - 08/2014
3Insulin (Novolin)FDA Link
09/2018 - 12/2001
3Coloring Agents (Dyes)IBA
08/2017 - 05/2003
3Interleukin-10 (Interleukin 10)IBA
12/2016 - 11/2011
3Ethanol (Ethyl Alcohol)IBA
05/2014 - 09/2001
3ProdrugsIBA
07/2013 - 07/2007
3AntibodiesIBA
01/2011 - 01/2001
3salicylhydroxamic acid (SHAM)IBA
12/2001 - 08/2001
2ImmunosorbentsIBA
03/2022 - 09/2014
2LuciferasesIBA
09/2021 - 11/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2021 - 02/2014
2CateninsIBA
05/2021 - 05/2014
2Glycyrrhizic Acid (Glycyrrhizin)IBA
01/2021 - 04/2018
2Oxygen (Dioxygen)IBA
11/2020 - 08/2005
2Complement System Proteins (Complement)IBA
08/2020 - 04/2016
2Blood Glucose (Blood Sugar)IBA
10/2019 - 09/2008
2Carisoprodol (Soma)FDA LinkGeneric
09/2019 - 01/2011

Therapy/Procedure

20Therapeutics
03/2022 - 01/2000
11Radiotherapy
03/2022 - 01/2011
10Drug Therapy (Chemotherapy)
10/2021 - 03/2004
4Segmental Mastectomy (Lumpectomy)
06/2020 - 04/2017
3Length of Stay
05/2022 - 10/2016
3Mastectomy (Mammectomy)
11/2021 - 06/2017
3Neoadjuvant Therapy
08/2019 - 06/2017
3Transplantation
08/2019 - 08/2000
3Aftercare (After-Treatment)
04/2015 - 01/2012
2Intravenous Injections
05/2021 - 03/2010